Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2002-8-16
pubmed:abstractText
To define duration and schemes of maintenance therapy, to evaluate cytarabine demand while treatment of acute promyelocytic leukemia (APL) with an original program 5D + Ifa + AT RA.
pubmed:language
rus
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0040-3660
pubmed:author
pubmed:issnType
Print
pubmed:volume
74
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
11-8
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:12181827-Adolescent, pubmed-meshheading:12181827-Adult, pubmed-meshheading:12181827-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:12181827-Bone Marrow, pubmed-meshheading:12181827-Daunorubicin, pubmed-meshheading:12181827-Drug Therapy, Combination, pubmed-meshheading:12181827-Female, pubmed-meshheading:12181827-Humans, pubmed-meshheading:12181827-Interferon-alpha, pubmed-meshheading:12181827-Leukemia, Promyelocytic, Acute, pubmed-meshheading:12181827-Liposomes, pubmed-meshheading:12181827-Male, pubmed-meshheading:12181827-Middle Aged, pubmed-meshheading:12181827-Neoplasm Proteins, pubmed-meshheading:12181827-Oncogene Proteins, Fusion, pubmed-meshheading:12181827-Pilot Projects, pubmed-meshheading:12181827-Polymerase Chain Reaction, pubmed-meshheading:12181827-Remission Induction, pubmed-meshheading:12181827-Tretinoin
pubmed:year
2002
pubmed:articleTitle
[Liposomal daunorubicin and interferon-alfa in combination with all-retinoic acid--a new regime for the treatment of acute promyelocytic leukemia].
pubmed:publicationType
Journal Article, Clinical Trial, English Abstract